开能健康
(300272)
| 流通市值：34.32亿 | | | 总市值：45.19亿 |
| 流通股本：4.64亿 | | | 总股本：6.11亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 417,607,625.01 | 1,840,952,624.84 | 1,355,645,119.71 | 889,329,811.28 |
| 营业收入 | 417,607,625.01 | 1,840,952,624.84 | 1,355,645,119.71 | 889,329,811.28 |
| 二、营业总成本 | 393,118,703.78 | 1,681,399,925.52 | 1,184,357,180.81 | 768,866,157.64 |
| 营业成本 | 256,787,960.48 | 1,122,582,731.97 | 812,640,558.04 | 523,635,412.42 |
| 税金及附加 | 2,853,811.42 | 10,624,014.54 | 7,171,997.59 | 4,747,643.34 |
| 销售费用 | 43,440,755.17 | 184,772,768.81 | 134,338,217.39 | 92,457,527.85 |
| 管理费用 | 54,071,738.08 | 242,491,979.49 | 165,619,708.35 | 107,545,072.6 |
| 研发费用 | 17,423,008.64 | 83,136,987.95 | 47,792,071.38 | 30,071,248.79 |
| 财务费用 | 18,541,429.99 | 37,791,442.76 | 16,794,628.06 | 10,409,252.64 |
| 其中:利息费用 | 10,691,497.51 | 44,868,760.72 | 25,597,457.76 | 16,387,687.42 |
| 其中:利息收入 | 4,772,796.75 | 24,211,743.17 | 16,485,859.72 | 10,305,639.59 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -1,103,068 | -14,053,615.04 | -32,140.71 | -32,140.71 |
| 加:投资收益 | -8,457,761.75 | -41,827,993.06 | -33,884,538.95 | -19,403,004.05 |
| 净敞口套期收益 | 0 | - | 0 | 0 |
| 资产处置收益 | 553,371.52 | -135,597.97 | -30,960.35 | 0 |
| 资产减值损失(新) | -141,889.8 | -1,962,397.03 | -1,292,170.9 | -1,272,871.85 |
| 信用减值损失(新) | 1,460,267.43 | -3,050,477.94 | 45,487.47 | 53,865.99 |
| 其他收益 | 2,421,667.31 | 11,768,527.75 | 7,945,921.04 | 5,324,123.81 |
| 四、营业利润 | 19,221,507.94 | 110,291,146.03 | 144,039,536.5 | 105,133,626.83 |
| 加:营业外收入 | 5,200.02 | 2,669,043.21 | 36,728 | 8,149.8 |
| 减:营业外支出 | 497,762.08 | 2,768,686.51 | 906,358.42 | 607,196.57 |
| 五、利润总额 | 18,728,945.88 | 110,191,502.73 | 143,169,906.08 | 104,534,580.06 |
| 减:所得税费用 | 5,911,176.79 | 30,120,353.95 | 23,718,278.16 | 16,900,087.67 |
| 六、净利润 | 12,817,769.09 | 80,071,148.78 | 119,451,627.92 | 87,634,492.39 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 12,817,769.09 | 80,071,148.78 | 119,451,627.92 | 87,634,492.39 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 5,343,350.8 | 56,008,942.61 | 95,353,246.99 | 70,145,892.58 |
| 少数股东损益 | 7,474,418.29 | 24,062,206.17 | 24,098,380.93 | 17,488,599.81 |
| 扣除非经常损益后的净利润 | 4,551,261.98 | 78,913,170.56 | 91,339,759.9 | 67,550,219.15 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | 0.1 | 0.17 | 0.12 |
| (二)稀释每股收益 | 0.01 | 0.1 | 0.17 | 0.12 |
| 八、其他综合收益 | -2,799,659.97 | -3,903,463.47 | -2,654,457.3 | -653,946.46 |
| 归属于母公司股东的其他综合收益 | -1,946,246.63 | -3,354,732.92 | -2,308,130.79 | -854,303.94 |
| 九、综合收益总额 | 10,018,109.12 | 76,167,685.31 | 116,797,170.62 | 86,980,545.93 |
| 归属于母公司股东的综合收益总额 | 3,397,104.17 | 52,654,209.69 | 93,045,116.2 | 69,291,588.64 |
| 归属于少数股东的综合收益总额 | 6,621,004.95 | 23,513,475.62 | 23,752,054.42 | 17,688,957.29 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |